Last updated: December 6, 2021
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Overall Status: Active - Recruiting
Phase
N/A
Condition
Prostate Cancer
Prostate Cancer, Early, Recurrent
Urologic Cancer
Treatment
N/AClinical Study ID
NCT05163197
W21_458
Ages > 18 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male, histological-confirmed disease of localized prostate cancer, TPLA treatment forPCa is performed
Exclusion
Exclusion Criteria:
- Age < 18 years
Study Design
Total Participants: 200
Study Start date:
October 01, 2021
Estimated Completion Date:
October 01, 2027
Connect with a study center
Amsterdam University Medical Centers
Amsterdam,
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.